Dioscorea prehensilis Ameliorates the Features of Preeclampsia in L-NG -Nitroarginine Methyl Ester (L-NAME) Preeclamptic Model doi.org/10.26538/tjnpr/v2i9.3.
Main Article Content
Abstract
Preeclampsia is a major cause of maternal and perinatal mortality and morbidity. Sadly, effective therapeutic strategies do not exist up to now for preeclampsia but antiplatelet agents, low dose aspirin in particular is considered as primary prevention in high risk patients. Dioscorea prehensilis (DP) belonging to the family Dioscoreaceae is used among locals in the treatment of severe inflammatory conditions. This study is aimed at studying the effect of DP on the components of preeclamptic syndrome in a rat model. The rhizome of DP was extracted by maceration in 80% methanol. Preeclampsia was induced by chronic inhibition of nitric oxide synthesis by L-NAME (50 mg/kg/day, orally) in pregnant rats. DP was administered at a dose of 500 mg/kg/day orally. Systolic blood pressure was measured using tail cuff method on day 20. Albumin/creatinine ratio in spot urine was assessed using standard protocol on day 19; plasma nitric oxide was quantified using commercially available kits on day 20 while histological analysis was done using standard procedures. The extract reduced the systolic blood pressure significantly when compared to the preeclamptic control (130.38±4.43 versus 92.28±23.33mmHg) and not significantly different from the normal control (108±3.41 mmHg). The mean albumin/creatinine
ratio was also reduced compared to the preeclamptic control though not significantly. Histological examination of the placenta shows that the extract reduced the severity of hypoplastic villi and intervillus congestion compared to the untreated group. In conclusion, DP ameliorates preeclampsia and may serve as a source of bioactive agents for the management of preeclampsia.
Downloads
Article Details
Section
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
How to Cite
References
Cunningham FG, Leveno KJ, Bloom SL. Williams obstetrics23rd ed. Toronto: McGraw Hill Medical, 2010; chapter 34. 706-756 p.
Khan KS, Wojdyla D, Say L. WHO analysis of causes of maternal death: a systematic review 2006.
NHBPEP. Report of the National High Blood Pressure Education Program Working Group on High Blood Pressure in Pregnancy (NHBPEP). Am J Obstet Gynecol. 2000; 183:S1–S22.
World Health Organization. A global brief on Hypertension. WHO Press, World Health Organization, 20 Avenue Appia, 1211 Geneva 27, Switzerland 2013.
Takei H, Nakai Y, Hattori N, Yamamoto M, Takeda S, Yamamoto M, Arishima K. The herbal medicines Saireito and Boiogito improve the hypertension of pre-eclamptic rats induced by Nω-Nitro-l-arginine methyl ester. Phytomed.2007; 14(9):591-600.
Roberts JM and Gammill HS. Preeclampsia: recent insights. Hypertens. 2005; 46(6):1243-1249.
Goldenberg RL and Rouse DJ. Prevention of premature birth. N Engl J Med. 1998;339(5):313-320.
Geysen HM, Schoenen F, Wagner D, Wagner R. A guide to drug discovery: Combinatorial compound libraries for drug discovery: an ongoing challenge. Nat Rev Drug Discov.2003; 2(3):222.
Lombardino JG and Lowe III JA. A guide to drug discovery: the role of the medicinal chemist in drug discovery—then and now. Nat Rev Drug Discov. 2004; 3(10):853.
Vuorela P, Leinonen M, Saikku P, Tammela P, Rauha JP, WennbergT, Vuorela H. Natural products in the process of finding new drug candidates. Curr Med Chem. 2004; 11(11):1375-1389.
Redman CWG. Current topic: pre-eclampsia and the placenta. Placenta 1991; 12:301–308.
Schiff E, Peleg E, Goldenberg M, Rosenthal T, Ruppin E, Tamarkin M, Barkai G, Ben-Baruch G, Yahal I, Blankstein
J, Goldman B. The Use of Aspirin to Prevent PpregnancyInduced Hypertension and Lower the Ratio of Thromboxane A2 to Prostcyclin in Relatively High-Risk Pregnancies. N Engl J Med. 1989; 321(6): 351-356.
Roberge S, Giguère Y, Villa P, Nicolaides K, Vainio M, Forest JC, von Dadelzen P, Vaiman D, Tapp S, BujoldE. Early administration of low-dose aspirin for the prevention of severe and mild preeclampsia: a systematic review and meta-analysis.Am J Perinatol 2012;29(07): 551-556.
Bujold E, Roberge S, Lacasse Y, Bureau M, Audibert F, Marcoux S, Forest JC, Giguère Y. Prevention of preeclampsia and intrauterine growth restriction with aspirin started in early pregnancy: a meta-analysis.Obstet Gynecol.2010; 116(2, Part 1): 402-414.
Organization for Economic Development (OECD). Guideline for testing of chemical. Guidance no 425. Up and Down procedure. 2001; Adopted: 17th December 2001.
Richer C, Boulanger H, Es‐Slami S Giudicelli JF. Lack of beneficial effects of the NO‐donor, molsidomine, in the L‐NAME‐induced pre‐eclamptic syndrome in pregnant rats. Br J Pharmacol. 1996; 119(8):1642-1648.
Cook JGH. Factors Influencing the Assay of Creatinine: Prepared for the Association of Clinical Biochemists' Scientific and Technical Committee. Ann Clin Biochem. 1975; 12(1-6):219-232.
Slot C. Plasma creatinine determination a new and specific Jaffe reaction method. Scand J Clin Lab Invest. 1965; 17(4):381-387.
Baravalle C, Salvetti NR, Mira GA, Pezzone N Ortega HH. Microscopic characterization of follicular structures in letrozole-induced polycystic ovarian syndrome in the rat. Arch Med Res. 2006; 37(7):830-839.
Änggård E. Nitric oxide: Mediator, murderer and medicine.Lancet 1994; 343:1199–206.
Yallampalli C and Garfield RE. Inhibition of nitric oxide synthesis in rats during pregnancy produces signs similar to those of preeclampsia. Am J Obstet Gynecol. 1993; 169(5):1316-1320.
Salas SP, Altermatt F, Campos M, Giacaman A, Rosso P. Effects of long-term nitric oxide synthesis inhibition on plasma volume expansion and fetal growth in the pregnant rat. Hypertens. 1995; 26(6):1019-1023.
Diket AL, Pierce MR, Munshi UK, Voelker CA, ElobyChildress S, Greenberg SS, Zhang XJ, Clark DA, Miller MJ. Nitric oxide inhibition causes intrauterine growth retardation and hind-limb disruptions in rats. Am J Obstet Gynecol.1994; 171(5):1243-1250.
Conrad KP and Lindheimer MD. Renal and cardiovascular alterations. In: Lindheimer MD, Roberts JM, Cunningham FG, editors. Hypertensive disorders in pregnancy. Stamford, CT: Appleton and Lange: 1999; 263-326 p.
Gant NF, Daley GL, Chand S, Whalley PJ, MacDonald PC. A study of angiotensin II pressor response throughout primigravid pregnancy. J Clin Invest. 1973; 52(11):2682-2689.
Molnár M, Sütö T, Tóth T, Hertelendy F. Prolonged blockade of nitric oxide synthesis in gravid rats produces sustained hypertension, proteinuria, thrombocytopenia, and intrauterine growth retardation. Am J Obstet Gynecol. 1994; 170(5):1458-1466.
Seligman SP, Buyon JP, Clancy RM, Young BK, Abramson SB. The role of nitric oxide in the pathogenesis of preeclampsia. Am J Obstet Gynecol. 1994; 171(4):944-948.
Amat N, Amat R, Abdureyim S, Hoxur P, Osman Z, Mamut D, Kijjoa A. Aqueous extract of dioscoreaoppositathunb. normalizes the hypertension in 2K1C hypertensive rats. BMC Compl Altern Med. 2014; 14(1):36.
Liu YH, Lin YS, Liu DZ, Han CH, Chen CT, Fan M, Hou WC. Effects of different types of yam (Dioscoreaalata) products on the blood pressure of spontaneously hypertensive rats. Biosci Biotechnol Biochem. 2009; 73:1371–1376.
Takei H, Nakai Y, Hattori N, Yamamoto M, Kurauchi K, Sasaki H, Aburada M. The herbal medicine Toki-shakuyakusan improves the hypertension and intrauterine growth retardation in preeclampsia rats induced by Nω-nitro-Larginine methyl ester. Phytomed. 2004; 11(1):43-50.
Takei H, Iizuka S, Yamamoto M, Takeda S, Yamamoto M, Arishima K. The herbal medicine Tokishakuyakusan increases fetal blood glucose concentrations and growth hormone levels and improves intrauterine growth retardation induced by Nω-Nitro-L-arginine methyl ester. J Pharmacol Sci. 2007; 104(4):319-328.
Page EW. The relation between hydatid moles, relative ischemia of the gravid uterus, and the placental origin of eclampsia. Am J Obstet Gynecol. 1939; 37(291-293):8.
Zhou Y, Damsky CH, Fisher SJ. Preeclampsia is associated with failure of human cytotrophoblasts to mimic a vascular adhesion phenotype. One cause of defective endovascular invasion in this syndrome? J Clin Invest. 1997; 99(9):2152-2164.
Huang Q, Gao Y, Yu Y, Wang W, Wang S, Zhong M. Urinary spot albumin: creatinine ratio for documenting proteinuria in women with preeclampsia. Rev Obstet Gynecol. 2012; 5(1):9.
Moiety S, El Attar R, El Kaffash D. Albumin to creatinine ratio in a random urine sample: Correlation with severity of preeclampsia. A.J.M.E. 2014; 50(2):39-142.
Baylis C and Engels K. Adverse interactions between pregnancy and a new model of systemic hypertension produced by chronic blockade of endothelial derived relaxing factor (EDRF) in the rat. Clinical and Experimental Hypertension. Part B: Hypertens. Pregnancy. 1992; 11(2-
:117-129.
Waugh J, Kilby MD, Lambert PC, Claire N, Shennan A, Halligan A. Urinary microalbumin/creatinine ratios: reference range in uncomplicated pregnancy. Clinl Sci. 2003; 104(2):103-107.
Hladunewich M, Karumanchi SA, Lafayette R. Pathophysiology of the clinical manifestations of preeclampsia. Clin. J. Am. Soc. Nephro. 2007;2(3):543-549.
Knox TA, Olans LB. Liver disease in pregnancy. N Engl J Med. 1996; 335(8):569-576.
Wang JJ, Liu YX, Wen D, Yu HS, Kang LP, Pang X, Zhao Y, Ma BP, Chen YD. Study on steroidal saponins from Dioscoreazingiberensis and their platelet aggregation activities. Zhongguo Zhong yaozazhi= Zhongguozhongyaozazhi= China J Chinese materiamedica.2014; 39(19):3782-3787.
American College of Obstericians and Gynecologists. Task Force Report on Hypertension in Pregnancy: American college of Obstertricians and Gynecologists, Washington, DC. 2013.
Walsh SW. Preeclampsia: an imbalance in placental prostacyclin and thromboxane production. Am J Obstet Gynecol. 1985; 152(3):335-340.
Norris LA, Gleeson N, Sheppard BL, Bonnar J. Whole blood platelet aggregation in moderate and severe pre‐eclampsia.B.J.O.G. 1993; 100(7):684-688.
Barron WM, Lindenheimer MD, Davison JM. Medical Disorders during Pregnancy. Third edition. Mosby, Inc. USA 2000